Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Focusing on the Greater Bay Area's innovation! HealthGen won the "Golden Wisdom Award" 2019 Outstanding Innovation Efficiency Award for Chinese Listed Companies

Published Time:

2019-11-21

On November 15th, at the award ceremony for the "Golden Wisdom Award" 2019 Financial World Value Selection Award-winning companies, which focuses on research and anchoring value, Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan Pharmaceutical Group")'s innovative capabilities were once again recognized, winning the "Golden Wisdom Award" 2019 Outstanding Innovation Efficiency Award for Chinese Listed Companies. As an important representative of China's large health industry, Health Yuan Pharmaceutical Group won the "Golden Wisdom Award" 2019 Outstanding Innovation Efficiency Award for Chinese Listed Companies for its outstanding performance in comprehensive value creation in economic, social, environmental, and governance aspects.

 

It is understood that the Financial World website, which sponsors the award, was established in 1999. It is a leading domestic financial and economic information provider jointly invested by IDG (USA) and Vertex (Singapore), and is currently one of the most influential Chinese financial websites globally. The award selection criteria are rigorous and comprehensive, with professional evaluations from multiple dimensions, including the company's technological innovation capabilities, R&D cycle, and R&D investment efficiency. Combined with low asset-liability ratio, the proportion of intellectual property rights, return on total assets, return on net assets, and cost-profit margin, the selection process filters listed companies with core competitiveness and significant contributions to industry development, selecting the best from the best and ultimately commending the outstanding ones.

 

 

Health Yuan Pharmaceutical Group's winning of the "Golden Wisdom Award" indicates that its development in the pharmaceutical and large health sectors and its excellent operating conditions have been affirmed by professional review institutions and numerous investors.

 

In recent years, under the leadership of Mr. Zhu Baoguo, Chairman of the Board, Health Yuan Pharmaceutical Group has developed into a professional, comprehensive pharmaceutical company covering four major fields: raw materials, OTC, prescription drugs, and health products. It has also been a pioneer in cultivating the potential domestic market for respiratory inhalation preparations, with comprehensive product layouts and leading R&D progress compared to its peers. The company's R&D work on respiratory drugs has made breakthrough progress, and the company is striving to build a leading domestic and world-class technology platform, laying a solid foundation for the company's future development and focusing on the Greater Bay Area's pharmaceutical innovation.